- Previous Close
1.5500 - Open
1.6000 - Bid --
- Ask --
- Day's Range
1.4000 - 1.7500 - 52 Week Range
1.1100 - 1.9700 - Volume
4,504,678 - Avg. Volume
3,063,950 - Market Cap (intraday)
6.793M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company's nasal sprays provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. It develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza. The company was incorporated in 2005 is headquartered in Ra'anana, Israel.
www.polyrizon-biotech.comRecent News: PLRZ
View More
Performance Overview: PLRZ
Trailing total returns as of 10/30/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PLRZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PLRZ
View MoreValuation Measures
Market Cap
6.67M
Enterprise Value
6.67M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-71.83%
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-669k
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
195k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-564.88k
Company Insights: PLRZ
PLRZ does not have Company Insights